The road ahead for functional foods: Promising opportunities amidst industry challenges
Future Postharvest and Food,
Journal Year:
2024,
Volume and Issue:
1(2), P. 266 - 273
Published: June 1, 2024
Functional
foods,
fortified
with
bioactive
compounds,
offer
health
benefits
beyond
basic
nutrition.
Despite
their
potential,
challenges
such
as
compound
instability,
scalability
issues,
and
regulatory
gaps
exist.
This
commentary
explores
role,
market
dynamics,
future
trends,
emphasizing
the
need
for
ongoing
research
effective
regulations.
In
dynamic
field
of
nutrition
science,
functional
foods
have
carved
a
significant
niche.
These
which
more
than
just
nutrition,
are
compounds
antioxidants
(e.g.,
phenolic
carotenoids,
omega-3
fatty
acids,
some
vitamins)
that
confer
health-promoting
disease-preventing
properties
(Barik
et
al.,
2022;
Khan
2013).
The
concept
amalgamates
principles
from
food
pharmacology,
thereby
offering
comprehensive
approach
to
well-being
(Granato
2020).
rise
in
interest
is
driven
by
shift
consumer
preference
toward
natural
health-enhancing
products
(Baker
2022a;
Topolska
2021).
As
societies
become
increasingly
health-conscious,
there
burgeoning
demand
can
enhance
health,
boost
performance,
mitigate
risk
disease.
trend
mirrored
rapid
expansion
market,
projected
witness
substantial
growth
coming
years
(Vergari
2010).
However,
journey
laboratory
laden
challenges.
encompass
technical
issues
related
stability
bioavailability
hurdles,
acceptance/trust.
these
challenges,
potential
realm
personalized
nutrition)
delivery
compounds)
microorganisms
probiotics)
vast
(Ahluwalia,
2021;
Gupta
Personalized
particular,
customizes
dietary
recommendations
individual
nutritional
needs,
holds
revolutionize
wellness
near
(Gupta
capacity
deliver
targeted
benefits,
ideally
suited
this
approach.
harnessing
necessitates
overcoming
scientific,
regulatory,
(Khan
2013;
Nazir
2019).
current
landscape
scientific
literature,
an
abundance
trending
publications
focusing
on
topic
foods.
despite
wealth
information
available,
noticeable
void
when
it
comes
concise
overview
captures
various
facets
gap
particularly
evident
areas
applications
within
industry.
Accordingly,
aims
provide
exhaustive
role
opportunities
they
present
both
consumers
industry,
exist
exciting
development
road.
It
delves
into
effects
bioactives,
dynamics
decline
supplements
preventive
strategies,
increasing
awareness
healthier
products.
paper
also
discusses
space
corresponding
including
manufacturing
process,
toxicity,
lack
clear
regulations,
limited
data
clinical
translation,
skepticism/awareness.
concludes
discussion
trends
effect
future.
Bioactive
diverse
group
molecules
(Kamiloglu
Kumar
2023).
They
exhibit
range
antioxidant,
anti-inflammatory,
antimicrobial,
antiatherogenic,
antithrombotic,
cardioprotective,
vasodilatory
Mohamed,
2015).
Antioxidants,
instance,
known
combat
free
radicals,
implicated
several
different
human
diseases
(Arshad
&
Ahmad,
found
variety
fruits,
herbs,
spices,
vegetables,
cereals,
legumes,
chocolate,
beverages
like
tea,
coffee,
or
wine
(Mohamed,
derived
plants,
biologically
active
proteins,
polyphenols,
phytosterols,
biogenic
amines,
carotenoids
conditions
cancer,
cardiovascular
diseases,
diabetes
(Samtiya
efficacy
depends
bioavailability,
be
influenced
factors
matrix,
processing,
storage,
differences
(Berkel
Kaşıkçı,
2023;
de
Freitas
Queiroz
Barros,
Baú
Betim
Cazarin,
Maróstica
Junior,
2022).
Bioavailability
denotes
degree
speed
at
component
(i.e.,
drug
metabolite)
absorbed
systemic
circulation,
thus
reaching
its
action
site.
Unfortunately,
oral
significantly
impacted
release
plant
solubility
gastrointestinal
fluid,
permeability
through
intestinal
epithelial
cells,
enzymatic
chemical
reactions
taking
place
tract
Barros
Nonetheless,
hold
promise
promoting
preventing
chronic
diseases.
Further
yet
needed
fully
understand
influencing
optimize
maximum
benefits.
Beyond
plant-derived
important
acknowledge
animal
sources
microorganisms.
For
often
fish,
been
widely
recognized
anti-inflammatory
cardioprotective
effects.
Similarly,
probiotics,
beneficial
microorganisms,
associated
improved
gut
immune
function
(Grand
View
Research,
examples
underscore
diversity
sources.
progresses,
anticipated
will
discovered
utilized
further
emphasizes
safety
profiles,
well
develop
systems
compounds.
global
was
valued
USD
280.7
billion
2021,
expand
annual
rate
8.5%
2022
2030
surge,
has
US
illustrated
Figure
1,
number
crucial
elements.
magnitude
upcoming
years.
One
primary
drivers
rising
fortifying
additives.
aware
impact
physical
mental
well-being,
seeking
out
not
only
satisfy
hunger
but
additional
led
surge
ingredients
vitamins,
minerals,
fibers,
acids
(Hilton,
2017).
Another
factor
contributing
consciousness
among
consumers.
With
prevalence
lifestyle-related
rise,
individuals
making
changes
improve
prevent
disease
(Daliri
Lee,
Functional/fortified
added
meet
growing
demand.
aging
population
another
critical
driver
market.
people
age,
needs
change,
play
meeting
needs.
calcium
vitamin
D
help
older
adults
maintain
bone
while
those
enriched
support
heart
(van
der
Zanden,
van
Kleef,
Wijk,
Trijp,
2014).
incidence
Chronic
disease,
diabetes,
cancer
prevalent,
diet
plays
prevention
management
properties,
therefore
becoming
essential
part
strategies
2015;
Essa
summary,
experiencing
growth,
additives,
consumers,
population,
continue,
expected
reach
new
heights
While
supplement
witnessing
slowdown,
categories
even
observing
negative
rates
(Natarajan
GR,
Wróbel
suggests
perceived
holistic
Kengpol
saw
astronomical
sales
gains
over
past
few
years,
see
normalize.
seeing
first
time
long
while,
industry
still
good
place.
10%
between
2020
C
cold-and-flu
ingredient
category
were
$586
million.
Nevertheless,
does
spell
doom
indicates
Preventive
focus
maintaining
diet,
gaining
popularity
(Bhargava,
2010;
Control
Prevention,
Sharma,
Luxita,
Yadav,
Akanksha,
due
(Sharma
Singh,
practical
sustainable
promotion,
context
healthcare
costs
burden
(Boone-Villa
2019;
contain
scavenge
radicals
show
anti-mutagenic,
anti-tumor,
neuroprotective
certain
physiological
response
reducing
(Barik,
Chowdhury,
Tewari),
promotion.
Consumers
well-being.
heightened
driving
alternatives
synthetic
additives
Bogue
Repar,
antioxidants,
seen
holistic,
interested
content
2022a).
reflected
probiotics.
force
behind
equally
ensure
well-informed
misled
claims
(Van
Kleef
2005;
Williams
Ghosh,
2008).
Misleading
create
false
perceptions
about
lead
unhealthy
choices
(Williams
Therefore,
education
communication
key
ensuring
make
informed
diet.
Educational
programs
increase
consumers'
understanding
initiatives
distinguish
scientifically
substantiated
potentially
misleading
(Franco-Arellano
2017;
overall,
said
health-conscious
increasing.
numerous
pose
used
change
yield
increases
small
large
quantities
(Bansal,
Poonia,
Kolluri,
Vasundhara,
Sharma
affect
taste,
texture,
final
product.
characteristics
containing
vegetable
extracts
bioactives
vary
depending
type
(Aqilah
Moreover,
unstable
degrade
during
processing
storage.
instability
result
loss
efficacy.
example,
susceptible
oxidative
degradation,
chemically
(Kandemir
compromises
minimizes
breakdown
processes
substances
reveal
C,
phenols,
flavonoids,
glycosides
interact
oxygen
convective
drying
phase,
especially
elevated
temperatures.
interaction
leads
reduction
high
reducibility
(Belwal
ElGamal
Thus,
careful
consideration
control
storage
incorporated
Scaling
up
production,
indeed
complex
process
meticulous
planning
execution.
scaling
simple
multiplying
quantities.
When
quantities,
change.
product
may
behave
same
way,
so
methods
adjusted
changed
achieve
desired
result.
peptides,
foodstuffs
values,
face
terms
original
bioactivity
under
(Hosseini
specific
manufacture,
finished
taste
texture.
Changes
sourcing
formula
adjustments,
operational
complexities
faced
scale-up
(Galanakis,
Sutton
2016).
Sourcing
larger
business
ways.
rewrite
hit
price
point,
unnecessary
delays.
use
novel
technologies
require
modifications
existing
processes,
complicating
(Avelar
Galanakis,
production
necessary
demand,
presents
Overcoming
requires
planning,
execution,
possibly
assistance
experts.
Food
encompasses
multiple
aspects,
safe
implementation
hygienic
proper
preparation
methods.
extends
fortification
consumption
provided.
pursuit
overlook
safety.
continues
evolve,
must
remain
forefront
research,
development,
regulation
efforts.
Additionally,
although
nanoparticles
promising
avenue
enhancing
toxicity
concern
(Kang
Rath
minute
particles,
unique
biological
ways
particles
cannot,
leading
harmful
(Sukhanova
2018).
rigorous
evaluations
do
health.
isolated
amounts,
toxic
concentrations
(Mlozi
2020;
Nana
2011).
secondary
metabolites
produced
playing
defense
mechanisms,
reproduction
systems,
concentration
At
concentrations,
adverse
effects,
stress,
DNA
damage,
apoptosis,
cell
death,
induction
inflammatory
responses
Vilas-Boas
dosage
compounds/ingredients
Regulations
country
(Birch
Bonwick,
Brown
Chan,
Heller,
2001;
Hoadley,
clear,
universal
regulations
uncertainty
manufacturers.
far,
Japan
definition
approval
(Díaz
contrast,
United
States
Canada
attempted
define
absence
framework.
Europe,
European
Union
adopted
working
Europe-wide
ambiguity
confusion
skepticism,
undermining
credibility
On
other
hand,
(Sato
Valls
well-defined
framework
successful
ensures
builds
trust
acceptance.
Such
would
products,
foster
trust,
ultimately,
Several
countries
excelled
setting
benchmarks
rest
world.
Japan,
pioneer
field,
introducing
term
"FOSHU"
(Foods
Specified
Health
Use)
classify
Japanese
government
implemented
stringent
standards
marketing
Finland
made
strides
area,
Finnish
Authority
actively
balanced
States,
FDA
regulates
conventional
requirements
claims.
involves
review
provides
claimed
highlight
importance
acceptance
similar
measures
harness
full
There
enough
valid
evidence
promotion
(Mohanty
Singhal,
2018;
Samtiya
demonstrated
translation.
refers
applying
discoveries
gleaned
laboratory,
clinical,
studies
(Homer-Vanniasinkam
Tsui,
2012;
Mlozi
More
how
body
validate
precise
mechanisms
exert
understood
(de
Kang
Furthermore,
depend
presence
Wijesekara
Xu,
hinder
professionals
Healthcare
hesitant
recommend
robust
supporting
skeptical
if
perceive
backed
solid
2022b).
our
2022a,
Baker
2021)
rapidly,
skepticism
remains
doubt
fueled
(Topolska
Van
2005).
suggest
correlation
intake
possible
advantages.
globally
accepted
influences
amount
proof
required
assertions
across
nations.
themselves
adequate
proof;
comprehend
significance
underpins
assertions.
differing
views
regarding
actual
Some
believe
primarily
promoted
strategy
rather
customers/consumers
(English,
Vergari
labels
promote
criticized
(Siro
2008;
observations
done
better
inform
linked
consuming
underscores
transparent
manufacturers
production:
mentioned
earlier
(Section
3.2),
(Subramanian
Anandharamakrishnan,
Regulatory
uncertainties:
stated
Section
3.4,
(Brown
Díaz
2001).
Grand
Need
investment
development:
development.
includes
developing
conducting
trials
(Heller,
Homer-Vanniasinkam
2012).
grow,
companies
likely
enter
To
date,
nations,
corporations
BASF,
Cargill,
General
Mills
Inc.,
GFR
Pharma,
Nutri-Nation,
Amway,
Arla
Foods
appear
channeling
resources
endeavors
undertaking
strategic
measures,
fortify
standing
edge
expansion,
propelled
merely
momentary
trend,
reflection
broader
societal
attitudes
educated
path
manufacturing,
data,
all
hurdles
overcome.
multidisciplinary
brings
together
researchers,
regulators,
looks
promising.
Advancements
technology
paving
way
innovative
solutions,
approaches
production.
Simultaneously,
helping
build
foundation
field.
one
thing
clear:
we
continue
explore
safe,
sustainable,
accessible
all.
open
dialogue
stakeholders.
concerted
efforts,
truly
live
Ali
Rashidinejad:
Conceptualization;
investigation;
funding
acquisition;
writing
-
draft;
methodology;
validation;
editing;
software;
project
administration;
resources.
author
declares
no
competing
financial
interest.
Data
sharing
applicable
article
created
analyzed.
Language: Английский
A bioactive fraction from the leaves of Ceiba pentandra (L.) Gaertn. exhibits antiproliferative activity via cell cycle arrest at the G1/S checkpoint and initiation of apoptosis via poly [ADP-ribose] polymerase 1 (PARP1) cleavage in HeLa cells.
Journal of Ethnopharmacology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 119363 - 119363
Published: Jan. 1, 2025
Language: Английский
Harnessing the immunomodulatory potential of natural products in precision medicine—a comprehensive review
Maya G. Pillai,
No information about this author
A. Helen
No information about this author
Published: June 27, 2024
Traditional
medicine
systems
worldwide
utilize
natural
products
(NPs),
including
plant-derived
compounds,
minerals,
and
organisms,
harnessing
their
healing
potential.
NPs
offer
a
rich
source
of
potential
drug
candidates,
driving
innovation
in
discovery.
Recent
breakthroughs
have
reignited
interest
the
therapeutic
benefits
compounds.
Clinical
applications
NP-based
immunotherapies,
such
as
curcumin
resveratrol
cancer
treatment,
highlight
diverse
pharmacological
properties.
However,
despite
these
advancements,
challenges
persist
clinical
implementation
NPs.
Issues
standardization,
regulatory
approval,
supply
sustainability
remain
significant
hurdles.
Overcoming
limitations
requires
concerted
effort
to
address
complexities
NP
development.
Nevertheless,
ongoing
research
efforts
interdisciplinary
collaboration
hold
promise
for
advancing
therapeutics,
paving
way
development
innovative
treatments
various
diseases.
In
world
precision
medicine,
new
chapter
unfolds
join
journey.
The
exploration
sources
bioactive
compounds
has
revealed
promising
prospects
therapeutics
medicine.
This
article
explores
within
context
It
examines
intricate
pathways
through
which
derived
from
nature
tailored
prospects,
emphasizing
role
interventions.
Exploring
synergy
between
at
molecular
level,
this
delineates
exciting
prospect
customized
treatments,
signifying
transformative
impact
on
modern
medical
care.
review
further
highlights
tailoring
based
individual
genetic
makeup
disease
characteristics.
Additionally,
it
discusses
addressing
issues
sourcing,
scalability,
considerations
realize
full
Language: Английский
Diversity of amyloid beta peptide actions
Reviews in the Neurosciences,
Journal Year:
2024,
Volume and Issue:
35(4), P. 387 - 398
Published: Jan. 28, 2024
Fibril
formation
by
amyloidogenic
proteins
and
peptides
is
considered
the
cause
of
a
number
incurable
diseases.
One
most
known
amyloid
diseases
Alzheimer's
disease
(AD).
Traditionally,
beta
Aβ40
Aβ42
(Aβs)
are
as
main
causes
AD
foremost
targets
in
fight.
The
efforts
pharmacology
aimed
at
reducing
Aβs
concentration
to
prevent
their
accumulation,
aggregation,
senile
plaques,
neuronal
death,
neurodegeneration.
However,
publications
have
demonstrated
certain
beneficial
physiological
effects
Aβs.
Simultaneously,
it
indicated
that
turn
into
pathological
due
development
body.
accumulation
C-
N-terminal
truncated
under
diverse
conditions
supposed
play
role
development.
significance
transformation
glutamate
residue
positions
3
or
11
catalyzed
glutaminyl
cyclase
making
them
more
degradation
resistant,
hydrophobic,
prone
well
participation
dipeptidyl
peptidase
IV
these
transformations
discussed.
experimental
data
presented
confirm
maintenance
physiological,
nonaggregated
state
plant
preparations.
In
conclusion,
this
review
suggests
fight
against
AD,
instead
removing
Aβs,
preference
should
be
given
treatment
common
Glutaminyl
can
treatment.
Flavonoids
preparations
possess
antiamyloidogenic
propensity
proposed
neuroprotective,
anticancer,
antidiabetic
food
additives.
Language: Английский